Cerebrovascular disease treatment [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.

====== Cerebrovascular disease treatment ======


[[Stent]]s and [[flow diverter]]s have revolutionized the [[cerebrovascular disease]] [[treatment]]. [[Guglielmi Detachable Coil]]s, flexible [[microcatheter]]s, and first-generation intracranial stents, such as [[Neuroform]] (Stryker Neurovascular) and [[Enterprise]] stents (Codman/DePuy-Synthes), have paved the way for the development of the [[Pipeline Embolization Device]] (PED) (ev3/Covidien/Medtronic) and other endovascular approaches.

Karsy M, etr al. discusses the historical development of flow diverter technologies from the PED to similar devices, such as the [[Surpass Evolve]] stent (Stryker Neurovascular), the Flow-Redirection Endoluminal Device ([[FRED]]; MicroVention, Inc.), the [[SILK]] stent (Balt Extrusion), and the [[p64]] Flow Modulation Device (Phenox). In addition, the potential use of drug-eluting stents and various bioresorbable scaffolds (e.g., poly-L-lactic acid, [[magnesium]]), new developments in stent material (e.g., thin-film [[nitinol]]), design (e.g., biocompatible polymers, embedded microcircuitry, flow models), and potential applications for flow diverters will be considered. Endovascular treatment of cerebrovascular disease is rapidly advancing via continued development of new technology
((Karsy M, Guan J, Brock AA, Amin A, Park MS. Emerging Technologies in Flow Diverters and Stents for Cerebrovascular Diseases. Curr Neurol Neurosci Rep. 2017 Oct 28;17(12):96. doi: 10.1007/s11910-017-0805-3. PMID: 29081013.))